Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Somberg

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
American Heart Journal|August 1, 1987
Refractoriness as a determinant of tachycardia inducibility in the right ventricleJ C Somberg, J Schwartz
American Journal of Therapeutics|October 1, 1996
Gender differences in drug therapyS Khosla, J C Somberg
American Heart Journal|October 1, 1986
Flecainide: a new antiarrhythmic agentJ C Somberg, D Tepper
Science (New York, N.Y.)|April 20, 1979
Localization of the neurally mediated arrhythmogenic properties of digitalisJ C Somberg, T W Smith
American Journal of Therapeutics|July 29, 1999
Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory processJ C Somberg, J S Borer
Journal of Clinical Pharmacology|November 1, 1991
Pharmacology and pharmacokinetics of amiodaroneM D Freedman, J C Somberg
American Journal of Therapeutics|September 11, 2001
Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humansV V Ranade, J C Somberg
Journal of Clinical Pharmacology|March 1, 1986
Esmolol: a novel ultra-short-acting beta-blocking agentD L Keefe, J C Somberg
European Journal of Pharmacology|February 15, 1979
The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected catJ C Somberg, H Bounous, B Levitt
American Heart Journal|May 1, 1996
Successful heart failure therapy is effective antiarrhythmia therapyS Khosla, C Duggal, J C Somberg
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
American Heart Journal|August 1, 1987
Refractoriness as a determinant of tachycardia inducibility in the right ventricleJ C Somberg, J Schwartz
American Journal of Therapeutics|October 1, 1996
Gender differences in drug therapyS Khosla, J C Somberg
American Heart Journal|October 1, 1986
Flecainide: a new antiarrhythmic agentJ C Somberg, D Tepper
Science (New York, N.Y.)|April 20, 1979
Localization of the neurally mediated arrhythmogenic properties of digitalisJ C Somberg, T W Smith
American Journal of Therapeutics|July 29, 1999
Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory processJ C Somberg, J S Borer
Journal of Clinical Pharmacology|November 1, 1991
Pharmacology and pharmacokinetics of amiodaroneM D Freedman, J C Somberg
American Journal of Therapeutics|September 11, 2001
Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humansV V Ranade, J C Somberg
Journal of Clinical Pharmacology|March 1, 1986
Esmolol: a novel ultra-short-acting beta-blocking agentD L Keefe, J C Somberg
European Journal of Pharmacology|February 15, 1979
The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected catJ C Somberg, H Bounous, B Levitt
American Heart Journal|May 1, 1996
Successful heart failure therapy is effective antiarrhythmia therapyS Khosla, C Duggal, J C Somberg
Pageof 14